Sign Up
OverviewAPI
Researchers have developed a blood test called OvaPrint for early-stage ovarian cancer, with a high accuracy rate. Galactica Pharmaceuticals has published data suggesting a survival benefit and reduction in viral load for its investigational RAGE fusion protein in COVID-19 patients. A Nomination Committee has been appointed for Immunovia AB (Publ), a company focused on the development of immunotherapies.

Ask a question